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Of the many presentations across the clinical spectrum of chronic venous disease, venous leg ulceration can be considered amongst the most important. Despite a prevalence of 1% in the general population, it accounts for an annual expenditure of 1-2% of the national health budget, equating to over $2.5 billion in the US and £300-£600 million in the UK. 1 Importantly, with prevalence increasing to 4% in the elderly 1 and significant negative effects on quality of life due to disability, social isolation and psychosocial burden, venous leg ulceration will continue to present an important challenge, particularly in light of the expected increase in prevalence in the next decade dictated by an ageing and increasingly obese population. Prevention and intensive management are key in this condition; to this end, numerous guidelines have been developed endorsed by a number of professional bodies and healthcare organisations.
Clinical guidelines provide evidence-based frameworks for healthcare professionals and patients. Recognised benefits include health outcome improvement, establishing standards for care in clinical decision making and reducing expenditure by promoting costeffective interventions. Despite regulatory body and editorial scrutiny, guideline recommendations may be influenced by subjective notions, such as the experience of the writing committee and analysis of data that are lacking, misleading, or subject to misinterpretation. In a chronic, highly prevalent, historical and expensive condition such as venous leg ulceration, general consensus between guideline recommendations is to be expected. However, is this actually the case?
Hippocrates (460-377 B.C.) was the first to provide advice, or guidance, on venous leg ulceration. Since then, numerous guidelines have been published from all over the world, particularly from the United States and Europe. This is a testament to the importance and relevance of venous ulceration; despite the attention, there is large heterogeneity on numerous fronts.
The largest factor determining this heterogeneity lies in the definition of levels of evidence and levels of recommendation. Although ''systematic'' assessment of the literature is performed by all guidelines, its appraisal differs quite importantly. Grading systems employed include those from the European Society of Cardiology, 2 the American College of Chest Physicians 3 and the Agency for Health Care Policy and Research 4 evidence criteria, to provide some examples; furthermore, guideline development groups have devised their own criteria for the assessment of levels of evidence and grades of recommendation. 5 This difference in grading systems results in similar recommendations being classified as high/medium/or low depending on how the literature has been interpreted by the different guideline committee groups. Translating this to clinical practice can result in variations in the level of care provided depending on which guideline (or evidence) is followed.
Another factor determining heterogeneity is structure, which does not always reflect the multidisciplinary nature key to venous leg ulcer guideline development. Venous leg ulceration is in the remit of vascular surgeons, phlebologists, angiologists, dermatologists, physicians, primary care physicians and nurses. Although guidelines are accessible to all healthcare professionals, it is to be expected that, depending on the overseeing body, guidelines may present information relevant to a specific category of healthcare professionals, leading to heterogeneity in the topics addressed and the need to refer to different guidelines to gain a comprehensive picture of a specific condition. This is particularly apparent in guidance relating to diagnosis and management, with ''secondary careoriented'' 2,3 guidelines concentrating on duplex ultrasound and the evidence for intervening on the superficial and/or deep venous systems, and ''primary care''-oriented 6 guidelines highlighting details on compression modalities and criteria for referral to specialist units.
Interestingly, certain themes are recurring between different guidelines. Taking a detailed history and performing a comprehensive physical examination are universally discussed. Ankle brachial pressure index (ABPI) measurement for both diagnostic and therapeutic reasons (e.g. with respect to the administration of compression bandaging) and duplex ultrasound assessment to assess both the superficial and the deep venous systems are also mentioned universally. Compression therapy, the cornerstone of venous ulceration management, is highly endorsed with high levels of evidence and grades of recommendation.
Heterogeneity, however, exists both at a diagnostic and therapeutic level. Interestingly, the use of the Clinical, Etiological, Anatomical, Pathophysiological (CEAP) classification in the assessment of the patient with venous ulceration is not mentioned by certain guidelines. 6, 7 This is somewhat surprising, considering that, despite its recognised limitations, CEAP is the internationally recognised and standardised classification system for chronic venous disease. The discussion regarding the use of imaging modalities other than duplex ultrasound is also limited to very few guidelines. 2, 3 Compression therapy, despite being endorsed by numerous guidelines, is described in detail only by a few; there is similar heterogeneity relative to the evidence and recommendations regarding topical treatments for venous ulceration, such as dressings or antibiotics. Finally, with respect to venous interventions, there is again large heterogeneity in terms of the recommended interventions 2, 3, 5 ; however, there is general consensus regarding the consideration of superficial venous surgery in patients with venous leg ulceration to prevent recurrence. Interestingly, deep venous intervention is assessed by few guidelines. 3, 4 It is therefore clear that, despite the existence of a large number of comprehensive clinical practice guidelines, consensus on certain aspects of venous leg ulcer assessment and treatment is still far from achieved. This makes the choice of the ''optimal guideline'' extremely difficult, and access to guidance for this important group of patients even more challenging.
This issue was raised six years ago; the Writing Group of the Pacific Vascular Symposium 6 stated that too many guidelines from different sources existed with disparate levels of evidence. 8 Despite this, over the last six years nothing has changed. It is time venous leg ulcer guidelines were created according to a standardised, evidence-based framework to make them as accessible and relevant to healthcare workers in clinical practice as possible. This is key to improving quality of care in a group of patients that is challenging to treat, with recurrence rates of up to 17% at one year 9 and a prevalence that is set to increase significantly in the next decade. The availability of high quality international guidelines, based on standardised measures for the assessment of the available evidence, will help improve the quality of care provided to these patients. A potential source of standardisation is represented by the Appraisal of Guidelines for Research and Evaluation (AGREE) 10 instrument, which can guide the development and reporting of clinical practice guidelines. This will provide the basis for the development of up to date, relevant, comprehensive guidance under the auspices of international societies. The identification of gaps in the existing knowledge will promote the development of novel, well-planned international studies to address this with high-level evidence.
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